FUNDAMENTALS · Fundamentals · TH Healthcare

Ratchaphruek Hospital Public (RPH) Fundamentals 2026 — P/E 15.8x, Revenue Analysis | SniperIQ

Ratchaphruek Hospital Public (RPH) is a TH-listed Healthcare company in Medical - Care Facilities with a market capitalization of ฿2.6B, trading at ฿4.98 on the SET. This SniperIQ fundamentals page covers Ratchaphruek Hospital Public's valuation (P/E 15.8x, P/B 1.5x), profitability (net margin 14.7%), revenue (฿1.2B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.

Market Cap฿2.6B
P/E (TTM)15.8x
Net Margin14.7%
Revenue (FY25)฿1.2B

Full research coverage

  • 8-Quarter Revenue & Margin Trend
  • Debt Maturity & Coverage
  • Peer Valuation Comparison
  • Free Cash Flow & Owner Earnings
  • AI Signal + Institutional Flow
  • DCF Valuation Model

Frequently Asked Questions

What is Ratchaphruek Hospital Public's market cap?

Ratchaphruek Hospital Public (RPH) has a market capitalization of approximately ฿2.6B, trading at ฿4.98 on the SET. Market cap moves with the live share price.

What is Ratchaphruek Hospital Public's P/E ratio?

Ratchaphruek Hospital Public's trailing twelve-month P/E ratio is 15.8x, with a price-to-book (P/B) of 1.5x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.

How profitable is Ratchaphruek Hospital Public?

Ratchaphruek Hospital Public runs a net profit margin of 14.7%, a gross margin of 32.7%, and an operating margin of 17.6%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.

How much revenue does Ratchaphruek Hospital Public generate?

Ratchaphruek Hospital Public reported revenue of ฿1.2B for fiscal year 2025, with net income of ฿182M and earnings per share (EPS) of 0.34. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.

Does Ratchaphruek Hospital Public pay a dividend?

Ratchaphruek Hospital Public offers a trailing dividend yield of about 5.6%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.

Is Ratchaphruek Hospital Public financially healthy?

Ratchaphruek Hospital Public carries a debt-to-equity ratio of 0.00x and a current ratio of 2.74x, with a market beta of -0.03. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.

Is Ratchaphruek Hospital Public a good stock to buy in 2026?

SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Ratchaphruek Hospital Public (RPH) the key facts are: market cap ฿2.6B, P/E 15.8x, revenue ฿1.2B, 52-week range 4.48-5.25. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.

Track Ratchaphruek Hospital Public's full fundamentals live

Get Ratchaphruek Hospital Public's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.

Related: DENTSPLY SIRONA (XRAY) fundamentals · GlycoNex Incorporation (4168) fundamentals · ShareHope Medicine (8403) fundamentals · Atai Beckley (ATAI) fundamentals · All stock fundamentals · AI signal library
Research Hubs: Fundamentals library · Screeners · Institutional positioning · Super investors · Daily signals · Platform comparisons